Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and Oxycodone for Anxiety in Painless Abortion
NCT06435949Phase 1Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jul 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of oxycodone in anxiety disorder, postoperative pain and postoperative depression, sponsored by Ruijin Hospital. Primary endpoint: Anxiety. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
anxiety disorderpostoperative painpostoperative depression
Beyond the preview
Go deeper on NCT06435949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06435949.